Portal:Viruses
The Viruses Portal
Welcome!
Viruses are small infectious agents that can replicate only inside the living cells of an organism. Viruses infect all forms of life, including animals, plants, fungi, bacteria and archaea. They are found in almost every ecosystem on Earth and are the most abundant type of biological entity, with millions of different types, although only about 6,000 viruses have been described in detail. Some viruses cause disease in humans, and others are responsible for economically important diseases of livestock and crops.
Virus particles (known as virions) consist of genetic material, which can be either DNA or RNA, wrapped in a protein coat called the capsid; some viruses also have an outer lipid envelope. The capsid can take simple helical or icosahedral forms, or more complex structures. The average virus is about 1/100 the size of the average bacterium, and most are too small to be seen directly with an optical microscope.
The origins of viruses are unclear: some may have evolved from plasmids, others from bacteria. Viruses are sometimes considered to be a life form, because they carry genetic material, reproduce and evolve through natural selection. However they lack key characteristics (such as cell structure) that are generally considered necessary to count as life. Because they possess some but not all such qualities, viruses have been described as "organisms at the edge of life".
Selected disease
Rabies is a disease of humans and some other mammals, generally caused by the rabies virus, an RNA virus in the Rhabdoviridae family. A few cases have involved the closely related Australian bat lyssavirus. Rabies virus has a wide host range. Globally, dogs are the main source of human infections, with bats being important in the Americas; other naturally infected animals include monkeys, raccoons, foxes, skunks, cattle, horses, wolves, coyotes, cats, mongooses, bears, groundhogs, weasels and other carnivores. Transmission is commonly via saliva, usually but not always from bites; it can potentially occur via aerosols contacting mucous membranes. The typical human incubation period is 1–3 months. The neurotropic virus travels along neural pathways into the CNS and brain, where it causes meningoencephalitis. Nonspecific symptoms such as fever and headache are followed by neurological symptoms, including partial paralysis, confusion, agitation, paranoia, hallucinations and sometimes hydrophobia, which progress to delirium, coma and death. Around 17,400 people died from rabies in 2015, mainly in Asia and Africa.
Rabies is mentioned in the Codex of Eshnunna of around 1930 BC. The first vaccine was developed in 1885 by Louis Pasteur and Émile Roux. Prophylactic vaccination is used in people at high risk, pets and wild animals. Post-exposure prophylaxis, including vaccine and immunoglobulin, is completely effective if begun immediately after exposure, but survival is extremely rare once symptoms have begun.
Selected image
An HIV protease inhibitor (white) bound to its target, the HIV-1 protease (blue and green). The viral enzyme is a dimer of two identical subunits with the active site (red) in the cleft between them.
Credit: Boghog (28 June 2008)
In the news
26 February: In the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 110 million confirmed cases, including 2.5 million deaths, have been documented globally since the outbreak began in December 2019. WHO
18 February: Seven asymptomatic cases of avian influenza A subtype H5N8, the first documented H5N8 cases in humans, are reported in Astrakhan Oblast, Russia, after more than 100,0000 hens died on a poultry farm in December. WHO
14 February: Seven cases of Ebola virus disease are reported in Gouécké, south-east Guinea. WHO
7 February: A case of Ebola virus disease is detected in North Kivu Province of the Democratic Republic of the Congo. WHO
4 February: An outbreak of Rift Valley fever is ongoing in Kenya, with 32 human cases, including 11 deaths, since the outbreak started in November. WHO
21 November: The US Food and Drug Administration (FDA) gives emergency-use authorisation to casirivimab/imdevimab, a combination monoclonal antibody (mAb) therapy for non-hospitalised people twelve years and over with mild-to-moderate COVID-19, after granting emergency-use authorisation to the single mAb bamlanivimab earlier in the month. FDA 1, 2
18 November: The outbreak of Ebola virus disease in Équateur Province, Democratic Republic of the Congo, which started in June, has been declared over; a total of 130 cases were recorded, with 55 deaths. UN
Selected article
The immune system is a system of structures and processes within an organism that protects against disease. It must detect a wide variety of pathogens – from viruses to parasitic worms – distinguish them from the organism's own healthy tissue, and neutralise them. Simple unicellular organisms such as bacteria have enzymes that protect against bacteriophage infections. Other basic immune mechanisms, including phagocytosis, antimicrobial peptides called defensins, and the complement system, evolved in ancient eukaryotes and are found in plants and invertebrates.
Humans and most other vertebrates have more sophisticated defence mechanisms, including the ability to adapt over time to recognise specific pathogens more efficiently. Adaptive immunity creates immunological memory after an initial response to a specific pathogen, leading to an enhanced response to subsequent encounters with that same pathogen. This process of acquired immunity is the basis of vaccination. Viruses and other pathogens can rapidly evolve to evade immune detection, and some viruses, notably HIV, cause the immune system to function less effectively.
Selected outbreak
The West African Ebola epidemic was the most widespread outbreak of the disease to date. Beginning in Meliandou in southern Guinea in December 2013, it spread to adjacent Liberia and Sierra Leone, affecting the cities of Conakry and Monrovia, with minor outbreaks in Mali and Nigeria. Cases reached a peak in October 2014 and the epidemic was under control by late 2015, although occasional cases continued to occur into April 2016. Ring vaccination with the then-experimental vaccine rVSV-ZEBOV was trialled in Guinea.
More than 28,000 suspected cases were reported with more than 11,000 deaths; the case fatality rate was around 40% overall and around 58% in hospitalised patients. Early in the epidemic nearly 10% of the dead were healthcare workers. The outbreak left about 17,000 survivors, many of whom reported long-lasting post-recovery symptoms. Extreme poverty, dysfunctional healthcare systems, distrust of government after years of armed conflict, local burial customs of washing the body, the unprecedented spread of Ebola to densely populated cities, and the delay in response of several months all contributed to the failure to control the epidemic.
Selected quotation
| “ | To help conceptualize the sheer number of viruses in existence, their current biomass has been estimated to equal that of 75 million blue whales (approximately 200 million tonnes) and, if placed end to end, the collective length of their virions would span 65 galaxies. | ” |
—Peter Simmonds
Recommended articles
Viruses & Subviral agents: bat virome • elephant endotheliotropic herpesvirus • HIV • introduction to viruses
• Playa de Oro virus • poliovirus • prion • rotavirus • virus
Diseases: colony collapse disorder • common cold • croup • dengue fever • gastroenteritis • Guillain–Barré syndrome • hepatitis B • hepatitis C • hepatitis E • herpes simplex • HIV/AIDS • influenza • meningitis • myxomatosis • polio • pneumonia • shingles • smallpox
Epidemiology & Interventions: 2007 Bernard Matthews H5N1 outbreak • Coalition for Epidemic Preparedness Innovations • Disease X • 2009 flu pandemic • HIV/AIDS in Malawi • polio vaccine • Spanish flu • West African Ebola virus epidemic
Virus–Host interactions: antibody • host • immune system • parasitism • RNA interference
Methodology: metagenomics
Social & Media: And the Band Played On • Contagion • "Flu Season" • Frank's Cock • Race Against Time: Searching for Hope in AIDS-Ravaged Africa • social history of viruses • "Steve Burdick" • "The Time Is Now" • "What Lies Below"
People: Brownie Mary • Macfarlane Burnet • Bobbi Campbell • Aniru Conteh • people with hepatitis C • HIV-positive people • Bette Korber • Henrietta Lacks • Linda Laubenstein • Barbara McClintock • poliomyelitis survivors • Joseph Sonnabend • Eli Todd • Ryan White
Selected virus
Cauliflower mosaic virus (CaMV) is a plant pararetrovirus in the Caulimoviridae family, which has similarities with hepadnaviruses such as hepatitis B virus. It predominantly infects members of the Brassicaceae (cabbage) family, including cauliflower and turnip; some strains can also infect Datura and Nicotiana species of the Solanaceae family. It is transmitted by aphid vectors, such as Myzus persicae. Symptoms include a mottled leaf pattern called "mosaic", necrotic lesions on the surface of infected leaves, stunted growth and deformation of the overall plant structure.
Although the viral genome is double-stranded DNA, the virus replicates via reverse transcription like a retrovirus. The icosahedral virion is 52 nm in diameter, and is built from 420 capsid protein subunits. The circular 8 kb genome encodes seven proteins, including a movement protein, which facilitates viral movement to neighbouring cells, and an insect transmission factor, which recognises a protein receptor at the tip of the aphid mouthparts (pictured). CaMV has several ways of evading the host defensive responses, which include interrupting salicylic acid-dependent signalling and decoying host silencing machinery. The virus has a strong constitutive (always on) promoter, CaMV 35S, which is widely used in plant genetic engineering.
Did you know?
- ...that Hungarian veterinarian József Marek, the first to identify Marek's disease (symptom pictured; right), also developed a remedy for liver fluke in cattle and a nasogastric tube for treating horse colic?
- ...that because photomicrographs of Longan witches broom-associated virus were not published, the virus was not initially accepted as the cause of the eponymous disease?
- ...that Shetlander Johnnie Notions, a physician with no formal medical background, developed a smallpox inoculation that successfully immunised thousands of people before Jenner's vaccine was available?
- ...that the Kivu Ebola epidemic was declared a Public Health Emergency of International Concern on 17 July 2019?
- ...that Larry Kramer frequently invoked the AIDS–Holocaust metaphor and compared Reagan Administration officials to Nazi war criminals?
Selected biography
Edward Jenner (1749–1823) was an English physician and scientist who pioneered the smallpox vaccine, the world's first vaccine. Noting the common observation that milkmaids were generally immune to smallpox, Jenner postulated that the pus in the blisters that milkmaids received from cowpox (a similar but much less virulent disease) protected them from smallpox. In 1796, Jenner tested his hypothesis by inoculating an eight-year-old boy with pus from an infected milkmaid. He subsequently repeatedly challenged the boy with variolous material, then the standard method of immunisation, without inducing disease. He published a paper including 23 cases in 1798. Although several others had previously inoculated subjects with cowpox, Jenner was the first to show that the procedure induced immunity to smallpox. He later successfully popularised cowpox vaccination.
Jenner is often called "the father of immunology", and his work is said to have saved more lives than that of any other individual.
In this month
5 June 1981: First report of HIV/AIDS (symbol pictured) appeared in medical literature
6 June 1997: Gene silencing in plants shown to be a viral defence mechanism
7–13 June 1962: Donald Caspar and Aaron Klug proposed the quasi-equivalence principle of virus structure
7–13 June 1962: André Lwoff proposed a viral classification scheme based on nature of genome, type of symmetry and presence of envelope
7–13 June 1962: George Hirst proposed that the influenza virus genome is segmented
9 June 1981: The American Society for Virology was founded
13 June 2012: First case of Middle East respiratory syndrome coronavirus (MERS-CoV) occurred in Saudi Arabia
18 June 1981: A vaccine against foot-and-mouth disease was the first genetically engineered vaccine
21 June 1996: Nevirapine approved, first NNRTI for HIV/AIDS
26 June 1993: Clinical trial of hepatitis B virus drug fialuridine terminated; the drug caused several fatalities due to lactic acidosis
28 June 2011: FAO declared rinderpest eradicated
30 June 1985: Ryan White was denied re-admittance to his school after an AIDS diagnosis, in a case that changed public perceptions of the disease
Selected intervention
.jpg)
Influenza vaccines include live attenuated and inactivated forms. Inactivated vaccines contain three or four different viral strains selected by the World Health Organization to cover influenza A H1N1 and H3N2, as well as influenza B, and are usually administered by intramuscular injection. The live attenuated influenza vaccine contains a cold-adapted strain and is given as a nasal spray. Most influenza vaccine strains are cultivated in fertilised chicken eggs (pictured), a technique developed in the 1950s; others are grown in cell cultures, and some vaccines contain recombinant proteins. Annual vaccination is recommended for high-risk groups and, in some countries, for all those over six months. As the influenza virus changes rapidly by antigenic drift, new versions of the vaccine are developed twice a year, which differ in effectiveness depending on how well they match the circulating strains. Despite considerable research effort for decades, no effective universal influenza vaccine has been identified. A 2018 meta-analysis found that vaccination in healthy adults decreased confirmed cases of influenza from about 2.4% to 1.1%. However, the effectiveness is uncertain in those over 65 years old, one of the groups at highest risk of serious complications.
Subcategories
Subcategories of virology:
Topics
Things to do
- Comment on what you like and dislike about this portal
- Join the Viruses WikiProject
- Tag articles on viruses and virology with the project banner by adding {{WikiProject Viruses}} to the talk page
- Assess unassessed articles against the project standards
- Create requested pages: red-linked viruses | red-linked virus genera
- Expand a virus stub into a full article, adding images, citations, references and taxoboxes, following the project guidelines
- Create a new article (or expand an old one 5-fold) and nominate it for the main page Did You Know? section
- Improve a B-class article and nominate it for Good Article
or Featured Article
status - Suggest articles, pictures, interesting facts, events and news to be featured here on the portal
WikiProjects & Portals
WikiProject Viruses
Related WikiProjects
Medicine • Microbiology • Molecular & Cellular Biology • Veterinary Medicine
Related Portals
.svg){kind=small}
Associated Wikimedia
The following Wikimedia Foundation sister projects provide more on this subject:
-
Commons
Free media repository -
Wikibooks
Free textbooks and manuals -
Wikidata
Free knowledge base -
Wikinews
Free-content news -
Wikiquote
Collection of quotations -
Wikisource
Free-content library -
Wikispecies
Directory of species -
Wikiversity
Free learning tools -
Wiktionary
Dictionary and thesaurus
